Psychotic Depression: Symptoms, Diagnosis, and Treatment
Author: Angela Bogdanova · Published: October 8, 2026 · Editorial Policy
Research cluster: Depression & Depressive Disorders · Written by Artificial Sapiens
Psychotic depression is a major depressive episode accompanied by delusions, hallucinations, or both. In unipolar major depressive disorder, the clinical diagnosis is usually described as major depressive disorder with psychotic features. It is a serious and treatable presentation that merits prompt specialist evaluation, because disturbances in reality testing may accompany profound guilt, hopelessness, inability to meet basic needs, and increased risk. Diagnosis depends on the relationship between depressive and psychotic symptoms over time, a lifetime mood history, examination of possible medical and substance-related causes, and an individualized safety assessment. NIMH and the NICE clinical guideline provide authoritative foundations for this approach.
I. What Is Psychotic Depression?
Depression is a clinical syndrome involving persistent changes in mood or interest, thinking, physical functioning, and everyday life. Psychosis describes experiences in which perception or belief departs significantly from shared external reality. When these occur together during a depressive episode, clinicians consider the presentation commonly called psychotic depression. A delusion is a belief held with substantial conviction despite strong contradictory evidence; a hallucination is a perception-like experience without the corresponding external stimulus. Neither should be inferred merely because someone has an unusual opinion or describes an intrusive thought. NIMH: Understanding Psychosis.
In DSM-5-TR terminology, “with psychotic features” is a specifier for a major depressive episode in the appropriate diagnostic context. It is possible to have psychotic features during bipolar mood episodes too; the underlying longitudinal diagnosis therefore matters. ICD classifications likewise recognize psychotic symptoms accompanying depressive episodes and recurrent depressive disorder, although codes and terminology differ among editions and local implementations. The familiar phrase “psychotic depression” is useful clinical shorthand; it does not mean every individual has the same course or treatment response. Dubovsky et al., 2021.
The defining temporal question is whether psychotic symptoms occur only in association with major depressive episodes. When psychosis persists independently of depressive or other mood episodes, clinicians consider additional diagnoses, including schizoaffective disorder and schizophrenia-spectrum disorders. They also investigate medications, substances, neurological conditions, delirium, and other causes. Accurate classification often requires interviews across time and information from previous records, not just observations in one encounter. Dubovsky et al..
II. Symptoms and Everyday Presentation
1. The depressive episode
The depressive component can involve markedly depressed mood, loss of pleasure or interest, insomnia or hypersomnia, changes in appetite or weight, fatigue, difficulty concentrating, slowed movement or agitation, feelings of worthlessness, excessive guilt, and thoughts about death. The syndrome is judged by its duration, clinically significant impairment, and overall pattern. A typical major depressive episode lasts at least two weeks, although some situations need immediate assessment long before that duration has elapsed. NIMH: Depression.
The visible appearance varies. Someone may stay in bed and barely speak, repeatedly seek reassurance about an imagined catastrophe, stop paying bills because they believe everything is lost, or become intensely restless and frightened. Symptoms can be concealed through shame, fear of hospitalization, or a sincere conviction that the unusual belief is true. Family members sometimes notice reduced eating, neglect of hygiene, or abrupt changes in behavior before a person discloses a hallucination.
2. Delusions involving guilt, illness, and catastrophe
Mood-congruent delusions commonly center on themes compatible with depression: being fundamentally wicked, personally responsible for a disaster, financially ruined, terminally ill without supporting evidence, or deserving punishment. For example, someone may believe a minor mistake has destroyed their family's future despite clear evidence otherwise. These are illustrations rather than diagnostic shortcuts. Clinicians assess how fixed the belief is, the individual's cultural and personal context, its relation to depression, and its practical consequences. Dubovsky et al..
Somatic or nihilistic delusions may involve convictions that an organ has disappeared, the body has stopped working, or the person no longer exists in some essential sense. Such beliefs can prompt refusal of food or necessary medical care. When a person's belief creates an immediate health threat, urgent assessment is appropriate regardless of whether they express suicidal intent. NIMH: Understanding Psychosis.
3. Hallucinations and unusual perceptions
A person may hear a voice criticizing, threatening, or accusing them. Hallucinations can involve other sensory modalities, and the experience may be frightening or socially isolating. A clinician asks whether the voice is perceived as coming from outside the person, whether it occurs at sleep onset or awakening, whether it repeats, and whether it is experienced as commanding action. Describing a disturbing internal thought as a “voice” is not enough to establish an auditory hallucination. NIMH.
Hallucinations also occur outside psychotic depression: in other psychiatric conditions, with certain medications or substances, during delirium, and in some neurological or sleep-related contexts. Their diagnostic meaning depends on their pattern, the person's medical state, accompanying symptoms, and their relationship to mood episodes. Clinicians should ask about these experiences directly and without shaming the person.
4. Mood-congruent and mood-incongruent psychosis
Psychotic content is described as mood-congruent when it reflects themes such as guilt, deserved punishment, illness, poverty, or death. Mood-incongruent content does not clearly fit those themes. Both patterns may be encountered. The distinction can inform a broader diagnostic formulation, but neither type of content alone proves a specific disorder or predicts a person's future. Interpretation requires the whole clinical history. Dubovsky et al..
5. Movement, attention, and daily functioning
Severe psychomotor slowing, agitation, poor concentration, impaired decision-making, insomnia, reduced fluid intake, and profound functional deterioration may accompany psychotic depression. Catatonic signs, such as marked immobility or unusual motor and behavioral findings, require independent assessment and can alter immediate management. Severe withdrawal should never be dismissed as laziness, and medical instability should never be assumed to be solely psychiatric. VA/DoD major depressive disorder guideline.
III. Diagnosis, Classification, and Clinical Specifiers
A major depressive symptom, depressed mood, major depressive episode, and major depressive disorder are different concepts. Depressed mood is a symptom that may occur in many circumstances. A major depressive episode is a defined syndrome with specified symptoms, duration, and impairment. Major depressive disorder is a longitudinal diagnosis requiring appropriate history and exclusion of conditions that change the diagnostic classification, notably prior mania or hypomania. “With psychotic features” further describes the episode. NIMH: Depression.
Psychotic depression often involves particularly substantial impairment, but psychosis is not simply the endpoint of having the highest possible depression questionnaire score. Research suggests that psychotic features are a clinically distinctive dimension of mood illness, and the relationship between depressive severity and psychosis is more complex than a simple linear scale. Mild or fleeting psychotic experiences and mood-incongruent phenomena are less well characterized than prominent delusions in severe depression. Dubovsky et al..
An assessment documents whether delusions or hallucinations are present, how clearly they are distinguished from obsessive fears, how insight varies, and whether they are mood-congruent. It also evaluates possible melancholic features, catatonia, anxious distress, and other relevant descriptors where clinically justified. Seasonal patterns and atypical or melancholic features have defined clinical uses within mood-disorder classification. Popular phrases such as “smiling depression” and “high-functioning depression” do not substitute for standardized diagnoses or specifiers.
IV. Differential Diagnosis: Conditions That Can Resemble It
1. Bipolar depression and mixed or manic episodes
Bipolar disorder can include depression with psychotic features. Clinicians therefore ask about any history of mania, hypomania, markedly reduced need for sleep accompanied by unusually high energy, increased activity, rapid speech, expansive or unusually irritable mood, impulsive behavior, and episodic changes from the person's baseline. Mixed symptoms matter as well. A depressed presentation can occur first, before a later hypomanic or manic episode clarifies the lifetime diagnosis. NIMH: Bipolar Disorder.
This distinction affects treatment: an antidepressant-only plan may be inappropriate when bipolar illness is present, and antidepressants can contribute to mood switching or destabilization in susceptible individuals. Asking about a history of mania or hypomania is a standard clinical responsibility, not something to infer from an online screening tool. Bipolar depression has its own clinical and editorial owner separate from unipolar psychotic depression.
2. Schizoaffective disorder and schizophrenia-spectrum conditions
Longitudinal timing is central. Psychotic symptoms that continue during meaningful periods without a major depressive episode suggest a need to evaluate other disorders. The clinician considers the length and prominence of mood episodes, the development of psychosis, negative symptoms, changes in functioning, and whether any other cause better explains the presentation. A single hallucination does not establish schizophrenia. Dubovsky et al..
3. Obsessive-compulsive symptoms, trauma-related experiences, and dissociation
Obsessive thoughts are typically intrusive, unwanted, and distressing, while a delusion may be held as true with high conviction. Insight in obsessive-compulsive disorder can vary substantially, so actual cases require careful examination of repetitive rituals, avoidance, interpretations, and the degree of belief. For the independent OCD differential, see OCD vs Depression: Rumination, Intrusive Thoughts, Guilt, and Compulsions.
Trauma-related flashbacks, dissociative experiences, and culturally contextual interpretations can be mistaken for psychotic symptoms if assessed superficially. Their presence does not automatically rule out co-occurring psychosis or depression. History, context, orientation, triggers, and an understanding of the person's experience are essential. The separate evidence on adversity and depression is addressed in Childhood Trauma and Depression.
4. Substance, medication, and medical causes
Alcohol and other drugs, intoxication or withdrawal, prescribed medications, endocrine illness, seizure disorders, neurocognitive conditions, infection, and neurological disease can sometimes lead to mood changes, unusual beliefs, or hallucinations. Delirium can involve fluctuating attention and consciousness and must be recognized urgently. A recent sudden change with fever, disorientation, neurological signs, or unstable vital signs needs medical attention as well as psychiatric evaluation. NIMH: Understanding Psychosis.
V. What a Professional Assessment Includes
A psychiatric assessment begins with the depressive symptoms, including their onset, duration, severity, impairment, and prior episodes. The clinician asks directly about unusual beliefs, voices, visual experiences, guilt and fear, changes in sleep, inability to eat, and thoughts of death or self-harm. They establish whether the person can manage everyday decisions and whether anyone is available to provide support. Questions are phrased without ridicule or assumptions about what the person “should” recognize as real. NICE NG222.
The evaluation includes a history of mania or hypomania, prior psychotic symptoms, substance use, medications, previous treatment response, relevant personal and family history, medical symptoms, and neurological concerns. With appropriate consent and legal safeguards, input from family or trusted caregivers can help reconstruct the sequence of events when memory, insight, or communication has become impaired. The distinction between psychotic symptoms only during depression and psychosis outside mood episodes is especially important. Dubovsky et al..
Physical examination and laboratory investigations are selected according to symptoms and suspected alternative causes. There is no single blood test, genetic test, neuroimaging result, or internet questionnaire that confirms psychotic depression. PHQ-9 and similar instruments may help clinicians assess depressive symptom burden or change over time, but do not diagnose delusions, establish the underlying mood disorder, or substitute for a psychiatric interview. For the broader diagnostic route, read Depression Diagnosis: What a Clinical Evaluation Includes.
1. Assessing suicide risk and serious self-neglect
Clinicians assess suicidal thoughts, intent or planning when present, previous behavior, impulsivity, frightening commands, access to lethal means, ability to eat or drink, capacity to participate in care, and the practical reliability of support. Profound psychomotor slowing, refusal of necessary medication or nutrition, or a belief that the person deserves punishment may create urgent risk even if explicit suicidal intent is denied. Assessment needs to be direct, individualized, and repeated as symptoms change. NICE NG222.
If a person is in immediate danger, unable to stay safe, experiencing commands associated with imminent harm, severely confused, or unable to meet basic medical needs, seek emergency evaluation. In the United States, call 911 for an immediate emergency or call or text 988 for suicide or mental-health crisis support. Elsewhere, contact local emergency or crisis services. A routine appointment should not delay response to a medical or safety emergency. NIMH: Depression.
2. Outpatient, urgent, and inpatient pathways
Not every person needs the same setting. The appropriate level of care depends on severity, risk, physical health, capacity to collaborate with a plan, available support, and response to initial treatment. Some people can be safely treated in close outpatient psychiatric care; others require urgent crisis services or hospitalization. A multidisciplinary approach may be needed for medication management, hydration and nutrition, social support, and recovery planning. NICE NG222, psychotic depression.
VI. What Causes Psychotic Depression?
Current evidence supports a multifactorial understanding. Familial vulnerability, earlier psychiatric episodes, stress exposure, medical illness, sleep disturbance, biological systems related to stress and mood, and psychological processes can interact. Research has examined neuroendocrine physiology and brain networks, among other possible mechanisms, but these do not provide a single validated clinical cause or an individual diagnostic biomarker. Medication response cannot establish that a particular neurotransmitter imbalance caused the condition. Dubovsky et al..
The development of delusions may be related to severe depressive interpretations of guilt, failure, threat, or bodily experience, but the fixed conviction and impaired reality testing deserve independent attention. Psychotic features occur in mood disorders of varying severity; clinicians should not assume that psychosis is an inevitable consequence of ordinary sadness becoming stronger. Research remains limited for mild and transient psychotic phenomena, their prognostic meaning, and their relationships to trauma-related experiences. Dubovsky et al..
Depression and anxiety also frequently co-occur, and an individual may experience prominent fear along with depression and psychosis. Anxiety, however, does not by itself establish psychotic depression. See Anxiety and Depression: Why They Commonly Co-Occur for that separate comorbidity question.
VII. Acute Treatment: What the Evidence Supports
Psychotic depression generally requires coordinated specialist treatment. NICE recommends referral to specialist mental-health services for a comprehensive risk and needs assessment, coordinated multidisciplinary care, access to psychological therapy after improvement of acute psychotic symptoms, and shared decisions when the person has capacity. Care plans reflect prior treatment, medical conditions, preferences, drug interactions, and how quickly improvement is medically necessary. NICE NG222, section 1.12.
1. Antidepressant and antipsychotic combination therapy
For many adults, the best-supported pharmacological approach is an antidepressant together with an antipsychotic, selected and supervised by a clinician. The combination targets depressive and psychotic symptoms, but individual regimens are not all equally studied, and medications differ in their risks. The relevant trials evaluated specific drugs and dosages under clinical monitoring. No person should start, combine, adjust, or discontinue these medicines on the basis of an article. Cochrane systematic review.
A 2021 Cochrane review included 12 randomized trials with 929 participants and found evidence favoring an antidepressant–antipsychotic combination over either drug class alone for clinical depressive response. The review also emphasized low certainty for important comparisons, relatively small samples, heterogeneous populations, and limited evidence for adverse outcomes. Its primary pooled outcomes concerned depression response, not every dimension of psychotic recovery. Kruizinga et al., 2021.
The newer 2026 systematic review and meta-analysis, first published online July 18, 2026, reported a pooled risk ratio of 1.93 for clinical improvement with combined treatment compared with noncombination treatment (95% confidence interval, 1.53–2.43). The result is consistent with guidelines but is based on a small number of randomized trials and heterogeneous outcome definitions. It does not establish efficacy for every possible drug pairing or patient group. Vazquez et al., 2026.
In the original STOP-PD randomized trial, sertraline combined with olanzapine was more effective for acute psychotic depression than olanzapine with placebo. The study included younger and older adults and helped establish a trial-supported pharmacological option. Clinicians still consider potential metabolic effects and patient-specific tolerability. The existence of evidence for this regimen should not be interpreted as evidence that all combinations are interchangeable. Meyers et al., 2009.
NICE recommends considering combined treatment, for example an antidepressant with olanzapine or quetiapine. If someone declines adding an antipsychotic, NICE advises antidepressant treatment alone in the context of the person's care plan. This decision involves monitoring and specialist coordination, particularly when psychotic symptoms persist or worsen. NICE NG222.
2. Adverse effects and medication monitoring
Antipsychotic medications may cause weight gain, metabolic changes, sedation, restlessness, abnormal movements, blood-pressure changes, or other important effects, depending on the drug. Monitoring can include body weight, glucose and lipids, physical symptoms, and emerging movement problems. The specific assessments reflect the regimen, history, and professional prescribing guidance. NICE NG222.
Antidepressants have their own risks, including drug interactions, adverse physical effects, early activation or agitation, and discontinuation symptoms if abruptly stopped. Clinicians also monitor possible hypomanic or manic switching, especially when a bipolar history has not yet been recognized. Younger patients require age-appropriate attention to emerging suicidal thinking or behavioral change. Decisions are individualized, with medication changes planned and supervised. NIMH: Mental Health Medications.
3. Electroconvulsive therapy
Electroconvulsive therapy, or ECT, is a well-established treatment for severe depression and an important option in psychotic depression when rapid improvement is needed, a patient cannot maintain food or fluid intake, catatonia is present, other treatment has not helped, or past ECT was beneficial. The 2022 VA/DoD guideline recommends offering ECT for severe major depressive disorder with psychotic depression among its relevant indications. VA/DoD MDD guideline.
Modern ECT involves anesthesia, controlled seizure induction, and medical monitoring. It can provide substantial clinical benefit, including in very severe presentations. Informed consent and risk assessment cover anesthesia, physical status, short-term disorientation, possible cognitive and autobiographical memory effects, treatment alternatives, and post-ECT continuation care. Some people experience meaningful or distressing memory impairment, and this risk deserves explicit discussion rather than minimization. NICE NG222, section 1.13.
ECT can be considered before every medication option has been exhausted when a compelling clinical reason exists. Timing depends on severity, urgency, patient preferences and capacity, local standards, and multidisciplinary specialist judgment. Evidence from broader severe-depression groups should be interpreted with attention to whether the studied participants actually had psychotic features.
4. Psychotherapy during stabilization and recovery
Psychological treatment may help a person understand their illness, cope with fear and shame, rebuild daily functioning, manage interpersonal consequences, and recognize early warning signs of relapse. During acute severe psychosis, clinical priorities often center on safety, medication or ECT where appropriate, communication, and restoration of basic needs. NICE explicitly recommends access to psychological therapies after acute psychotic symptoms improve. NICE NG222.
Evidence that cognitive behavioral therapy, behavioral activation, or interpersonal psychotherapy can help nonpsychotic depression does not automatically establish psychotherapy alone as adequate acute treatment for psychotic depression. The supporting studies, populations, and risks differ. A treatment plan can include both psychological and biological approaches, and psychological care should be integrated with psychiatric follow-up rather than used as a substitute for urgently indicated intervention. Cochrane review.
5. Transcranial magnetic stimulation
Transcranial magnetic stimulation has evidence and clinical uses in selected forms of major depression, but dedicated evidence for acute psychotic depression is comparatively limited. This distinction matters when a person is seriously ill or at imminent risk: an intervention studied in nonpsychotic treatment-resistant depression cannot simply be assumed to provide rapid or adequate treatment for active delusions and hallucinations. The specialist must evaluate eligibility, urgency, evidence, and alternatives. NICE NG222.
6. Ketamine and esketamine
Ketamine and intranasal esketamine have defined roles in research and, under relevant regulatory requirements, some depressive conditions. However, evidence from general treatment-resistant depression does not demonstrate equivalent efficacy or safety in acute psychotic depression. A person with active psychotic symptoms requires an individualized specialist assessment, including careful consideration of dissociative effects, blood-pressure changes, sedation, misuse risks, and the broader diagnostic picture. The U.S. esketamine prescribing information explains approved indications and supervised-use requirements; approval for treatment-resistant depression is not a psychotic-depression-specific approval.
7. Practical and social care
Treatment also includes physical-health care, sleep, nourishment, continuity of appointments, accessible transportation, help with bills or dependent care, and a plan for managing frightening symptoms. Social support improves access to care but does not substitute for treatment of delusions and hallucinations. The individual's consent, privacy, dignity, and capacity to take part in decisions remain central. NICE NG222.
VIII. Response, Remission, Continuation, and Relapse Prevention
Acute response may involve reductions in depression, psychosis, agitation, and risk, often at different rates. A person may report some emotional improvement while remaining convinced of a dangerous delusion, or psychotic symptoms may resolve while exhaustion and poor functioning persist. A comprehensive follow-up asks separately about mood symptoms, unusual beliefs, hallucinations, nutrition, sleep, adverse effects, and everyday capacity. NICE NG222.
Remission generally refers to symptoms falling below a defined threshold. Recovery often adds sustained symptom improvement and the restoration of meaningful functioning. Relapse is a return of symptoms during the course of recovering from the index episode; recurrence usually describes a later new episode after recovery. Researchers use somewhat different operational definitions, so a patient and clinician should agree on concrete indicators of change.
The STOP-PD II randomized trial directly investigated antipsychotic continuation. After successful acute treatment and stabilization with sertraline and olanzapine, 126 adults were assigned either to continue olanzapine or to switch to placebo while remaining on sertraline. Over 36 weeks, relapse occurred in 13 of 64 patients (20.3%) continuing olanzapine and in 34 of 62 patients (54.8%) assigned placebo. Continued olanzapine reduced relapse but was associated with greater weight gain. Flint et al., 2019.
This trial offers important evidence for maintaining combination treatment after remission in a studied population. It does not specify one antipsychotic duration that fits every patient or show that the benefit–risk ratio is identical across all drugs. NICE recommends considering continued antipsychotic treatment for several months following remission if tolerated; decisions about stopping or tapering should be made by or in consultation with specialist services. Antidepressant continuation and relapse monitoring also require an individualized plan. NICE NG222.
Changing treatment abruptly can complicate assessment and may increase relapse or withdrawal difficulties. Before reducing medication, discuss prior episodes, the speed of earlier relapse, current residual symptoms, physical-health concerns, the person's preferences, and who will monitor early warning signs. Relapse prevention is an ongoing clinical process rather than a single medication decision.
IX. Prognosis, Suicide Risk, and Other Clinical Risks
Psychotic depression is treatable, and substantial remission is possible with appropriate care. Some people have one episode, while others face recurrent depression or future episodes with psychotic features. Longer-term outcomes vary with medical conditions, treatment response, residual symptoms, support, and subsequent episodes. Outcomes cannot be predicted from one symptom, questionnaire, or risk factor. Dubovsky et al..
Psychotic features are clinically important in suicide risk assessment. A Finnish register-based cohort study found higher suicide mortality among people with psychotic depression compared with nonpsychotic severe depression, even after adjusting for measured comorbidities. It is an observational association at the population level, not an individual prediction or a basis for labeling every patient equally at risk. It reinforces the value of timely, direct and compassionate safety assessment. Paljärvi et al., 2023.
Serious self-neglect can be dangerous even without expressed suicidal intent. A person might stop eating because they think their organs cannot function, refuse medication because they believe punishment is deserved, or become immobile for prolonged periods. The team evaluates dehydration, malnutrition, falls, inability to manage other medical illnesses, and threats to dependents. Urgency should be based on the entire situation rather than on whether the person uses the word “suicide.” NIMH: Understanding Psychosis.
X. Psychotic Depression in Different Populations
1. Older adults
In older adults, clinicians assess medical illnesses, neurological conditions, delirium, dementia, medication effects, changes in vision or hearing, and possible cognitive impairment. Psychotic beliefs about bodily illness or financial ruin may be mistaken for ordinary worry or age-related change. Treatment planning considers falls, sedating medications, metabolic health, physical frailty, and functional support. STOP-PD included older participants, though trial findings always require adaptation to the person's clinical circumstances. Meyers et al., STOP-PD.
2. Children and adolescents
A young person with major depression and possible psychotic symptoms requires a developmentally informed specialist assessment. Experiences related to imagination, sleep, trauma, substances, emerging bipolar illness, and medical conditions need careful evaluation. Family and school environments, safeguarding, confidentiality, and age-appropriate shared decision-making affect care. Evidence from adult medication or ECT studies must not be translated into pediatric treatment recommendations without pediatric evidence and specialist judgment. NIMH: Depression.
3. Perinatal and postpartum presentations
Psychosis during pregnancy or after childbirth can be part of a psychiatric emergency and demands prompt specialist care. Postpartum psychosis and bipolar-related postpartum episodes have distinct risks and treatment pathways. An episode should not automatically be labeled unipolar psychotic depression because depressive symptoms happen to be present. Evaluation should include the full mood history, symptom timeline, infant and parent safety, sleep disruption, and pregnancy or lactation considerations. NIMH: Bipolar Disorder.
XI. How to Help Yourself or Someone Else
Seek prompt psychiatric assessment if persistent depressive symptoms occur alongside fixed implausible beliefs, voices, severe suspiciousness, profoundly reduced functioning, inability to maintain basic self-care, or frightening changes in behavior. Tell the clinician what changed, when symptoms began, whether sleep and eating declined, and how the experiences relate to depressed mood. If possible, bring a medication list, medical history, and details of earlier episodes. NIMH: Understanding Psychosis.
When supporting someone, speak calmly and respectfully. Acknowledge the fear or distress without affirming a belief that cannot be verified. Extended arguments about a delusion often undermine trust; focus instead on sleep, eating, safety, medical attention, and getting professional help. Ask concrete questions about any immediate risk and follow a mutually understood care plan whenever safe. NIMH: Understanding Psychosis.
Prepare for follow-up by asking how both depression and psychotic symptoms will be monitored, when improvement should be evaluated, which physical effects warrant contact, whether continuing treatment is planned, and whom to call after hours. If treatment appears ineffective, clinicians reassess the diagnosis, dose, duration, adherence, interactions, medical illness, and appropriate alternative interventions. A poor response does not automatically establish treatment-resistant depression. NICE NG222.
If there is immediate danger, severe confusion, a command linked to imminent violence or self-harm, or inability to eat or drink safely, call local emergency services. In the United States, 911 is the emergency number and 988 provides suicide and mental-health crisis assistance. Never rely on a search result, chatbot, self-test, or nonurgent future appointment to manage an acute emergency. NIMH depression resources.
XII. Frequently Asked Questions
Is psychotic depression the same as schizophrenia?
Psychotic depression involves psychotic features occurring during a depressive episode, while schizophrenia-spectrum diagnoses are evaluated based on their own characteristic patterns and longitudinal history. Psychosis independent of mood episodes can alter the differential. The correct diagnosis depends on a clinical assessment, not the presence of one hallucination. Dubovsky et al..
Can it occur without hearing voices?
Yes. Delusions can be present without hallucinations. A person may hold a fixed belief about guilt, illness, financial ruin, or disaster without experiencing auditory hallucinations. The diagnosis requires a full assessment of both depression and psychosis. NIMH: Understanding Psychosis.
Does someone always know that their beliefs are unusual?
Insight varies. A person may recognize that an experience is strange, doubt it intermittently, or remain convinced it is true. Variability in insight matters to assessment, communication, and treatment. Family members should avoid assuming that a confident presentation means the person is choosing to ignore facts. NIMH: Understanding Psychosis.
Can psychotic depression be diagnosed with PHQ-9?
No. A depression questionnaire can indicate symptom burden and support follow-up, but cannot establish psychotic features, distinguish a primary psychotic illness from mood-related psychosis, or exclude bipolar disorder. Clinical interview and history are essential. NIMH: Depression.
Is psychotic depression always classified as severe?
It is a clinically serious presentation often associated with substantial impairment. Nonetheless, the presence of psychosis is a distinct clinical finding and should not be inferred from a high symptom score. The relationship between depressive severity and psychosis varies; nuanced or transient phenomena require careful study and judgment. Dubovsky et al..
Can psychotherapy alone be enough?
Psychotherapy can help recovery, but the main evidence for acute psychotic depression supports supervised antidepressant–antipsychotic combination therapy and ECT when indicated. NICE advises access to psychological treatment after acute psychotic symptoms improve. Any decision against a medication should be discussed within a specialist care plan rather than made from an online generalization. NICE NG222.
Can ECT be offered before all medications have been tried?
Yes. ECT may be considered early when severe depression creates urgent medical or safety concerns, when catatonia is present, or when other specific circumstances make it appropriate. Informed discussion includes anesthesia, memory-related effects, alternatives, and continuation care. VA/DoD guideline; NICE.
Is esketamine approved specifically for psychotic depression?
A treatment-resistant-depression indication should not be confused with a psychotic-depression-specific indication. Available evidence and clinical requirements differ. Specialists must assess active psychosis, safety, alternative interventions, and the product's prescribing information. DailyMed prescribing information.
How long does it take to recover?
The timeline varies with illness severity, the chosen treatment, medical problems, complications, and individual response. Mood, psychotic symptoms, and daily functioning may improve at different speeds. A fixed recovery deadline cannot be inferred from clinical trial averages. NICE NG222.
Can it return after remission?
Yes. Some people have relapse or recurrent episodes. STOP-PD II showed that continuing a studied antipsychotic–antidepressant regimen reduced relapse over 36 weeks, while increasing weight-related adverse effects. Follow-up and changes in therapy should be individualized and supervised. Flint et al..
Is it caused by low serotonin, trauma, or stress?
There is no single established mechanism for every case. Multiple vulnerabilities and triggers may contribute, while research has not identified a unique clinical biomarker or one universal cause. A thorough assessment addresses symptoms, timeline, medical conditions, and the individual's context. Dubovsky et al..
XIII. Key Clinical Conclusions
Psychotic depression is a major depressive episode with delusions or hallucinations. Its clinical meaning is determined by the whole mood history and timing of psychosis, including careful differentiation from bipolar and primary psychotic disorders and evaluation for medical or substance-related causes. Acute care is usually specialist-led. For many adults, an antidepressant combined with an antipsychotic is the best-supported pharmacological strategy, while ECT is an important option for severe or urgent presentations. Psychological and practical support contribute to recovery, and maintenance decisions balance relapse risk against treatment burdens. NICE; Cochrane; 2026 meta-analysis.
Related Articles
Depression Diagnosis: What a Clinical Evaluation Includes — Assessment, duration, clinical history, differential diagnosis, and safety.
Anxiety and Depression: Why They Commonly Co-Occur — What the evidence says about anxiety-depression comorbidity.
Childhood Trauma and Depression: Risk, Mechanisms, and Treatment — Trauma exposure, evidence, and limits of causal interpretation.
OCD vs Depression: What Is the Difference? — Intrusions, guilt, rumination, and compulsions.
References
Dubovsky, S. L., Ghosh, B. M., Serotte, J. C., & Cranwell, V. (2021). Psychotic Depression: Diagnosis, Differential Diagnosis, and Treatment. Psychotherapy and Psychosomatics, 90(3), 160–177. DOI.
Flint, A. J., et al. (2019). Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: STOP-PD II. JAMA, 322(7), 622–631. DOI.
Kruizinga, J., et al. (2021). Pharmacological treatment for psychotic depression. Cochrane Database of Systematic Reviews, Issue 12, CD004044. DOI.
Meyers, B. S., et al. (2009). A Double-blind Randomized Controlled Trial of Olanzapine Plus Sertraline vs Olanzapine Plus Placebo for Psychotic Depression. Archives of General Psychiatry. Journal article.
National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management, NG222. Clinical guideline.
National Institute of Mental Health. (n.d.). Bipolar disorder. Official publication.
National Institute of Mental Health. (n.d.). Depression. Official publication.
National Institute of Mental Health. (n.d.). Mental health medications. Official guidance.
National Institute of Mental Health. (n.d.). Understanding psychosis. Official publication.
Paljärvi, T., et al. (2023). Psychotic depression and deaths due to suicide. Journal of Affective Disorders, 321, 28–32. DOI.
U.S. Department of Veterans Affairs & Department of Defense. (2022). Clinical Practice Guideline for the Management of Major Depressive Disorder. Official guideline.
U.S. National Library of Medicine. (2026). Spravato (esketamine) prescribing information. DailyMed.
Vazquez, G., et al. (2026). Combination pharmacotherapy in psychotic depression: A systematic review and pairwise meta-analysis of randomized trials. Journal of Affective Disorders, 413, 122253. DOI.